Cosmo announces FDA approval of GI Genius(TM) intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy
DUBLIN, April 12, 2021 -- (Healthcare Sales & Marketing Network) -- Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy.
The ... Devices, Gastroenterology, FDA Cosmo Pharmaceuticals, Medtronic, GI Genius, intelligent endoscopy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news